Flowvium

公司比较

并排比较供应链位置、机构信号和新闻间隙评分。

VS

市值区间

超大型vs巨型

链条角色

leadervsleader

间隙评分

N/AvsN/A

IB活动

N/AvsN/A

营收结构比较

LLY
NVDA
LLY

Eli Lilly and Company

LLY · pharma-biotech

leader超大型 ($100B+)
完整资料

简介

Eli Lilly is the world's most valuable pharmaceutical company, propelled by the blockbuster GLP-1 receptor agonist tirzepatide (Mounjaro/Zepbound) for diabetes and obesity. Its Alzheimer's antibody donanemab and strong oncology pipeline give it one of the most promising drug portfolios in the industry.

成立时间

1876

员工人数

43,000+

总部

Indianapolis, Indiana, USA

营收

$52.8B

Diabetes & Obesity52%
Oncology18%
Immunology12%
Neuroscience10%
Other (Insulin Legacy)8%

新闻缺口信号

此股票代码没有新闻缺口数据。

机构信号

此代码没有13F信号记录。

关键关系

NVO· Novo Nordisk
competitor
PFE· Pfizer Inc.
competitor
REGN· Regeneron Pharmaceuticals
competitor
MRNA· Moderna, Inc.
partner
NVD

NVIDIA Corporation

NVDA · semiconductors

leader巨型 ($1T+)
完整资料

简介

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

成立时间

1993

员工人数

32,000+

总部

Santa Clara, California, USA

营收

$130.5B

Data Center78%
Gaming12%
Professional Visualization4%
Automotive & Robotics4%
OEM & Other2%

新闻缺口信号

此股票代码没有新闻缺口数据。

机构信号

此代码没有13F信号记录。

关键关系

TSM· Taiwan Semiconductor Manufacturing Company
supplier
005930.KS· Samsung Electronics
supplier
000660.KS· SK Hynix
supplier
MU· Micron Technology
supplier
MSFT· Microsoft Corporation
customer